Quantcast

Ivera Medical Announces Patent Award for Curos(R) Port Protectors

August 3, 2011

Patent covers innovative device for blood stream infection prevention.

San Diego, CA (PRWEB) August 02, 2011

Ivera Medical Corporation announced today that it has been awarded its second United States Patent for its innovative disinfecting cap technology. U.S. Patent No. 7,985,302 B2 covers vented disinfecting caps designed to be used with luer-activated IV valves and which contain a compressible cleaning material impregnated with a cleaning agent which is adapted to swab and clean the IV port.

IV therapy is the primary route for drug therapy in the acute care setting. Nearly all hospitalized patients have some type of a vascular access device inserted to improve the safety and efficacy of their treatment. However, traditional IV access management techniques, including “scrub the hub” protocols have failed to protect patients as evidenced by the approximately 87 percent of bloodstream infections associated with the presence of some type intravascular device.

Ivera Medical’s Curos® Port Protector is a simple, innovative, disposable medical device that guards against bloodstream infection. With two dispenser options””the Curos Strip or individual Curos””nurses can conveniently comply with disinfection protocols by simply peeling the foil seal off the distinctive green cap and twisting Curos over the top of any luer-activated IV access port or needleless valve. Inside Curos a 70% IPA (isopropyl alcohol) saturated sponge-like foam automatically provides effective, consistent and reliable passive disinfection of the port. The use of Curos eliminates training and technique-related issues while providing an unequivocal indicator that an IV access site is clean.

“The patent award is a strong recognition of the fundamental innovation Curos brings to patient safety,” stated Bob Rogers, chief executive officer of Ivera Medical. “The issuance of this new patent significantly strengthens our market position and underscores our commitment to deliver the best possible IV port protection solution to hospitals and patients in the US and abroad.”

About Ivera Medical

Ivera Medical Corporation is focused on the design, development, manufacture, marketing and sale of products that help healthcare providers reduce facility-acquired patient infections. Curos®, manufactured in Carlsbad, CA, is the first disinfecting cap to be marketed in the U.S. and has received FDA’s 510(k) market clearance. For more information about Curos® and Ivera Medical, visit the website at http://www.iveramed.com.

# # #

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/8/prweb8679431.htm


Source: prweb



comments powered by Disqus